Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Targeting Rare Diseases
Posted on March 20th, 2017 by Sherry Winter in Pharma R&D
What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. (more…)
Making Medicine More Precise
Posted on March 13th, 2017 by Christy J. Wilson in Pharma R&D
Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, (more…)
Personalized vs. Precision Medicine
Posted on February 3rd, 2017 by Dr. Anton Yuryev in Pharma R&D
Last year was a year of impetus for precision medicine. Former President Obama’s budget for the 2016 fiscal year included $215 million for the National Institutes of Health (NIH), (more…)
Start-Up Spotlight: Eudendron
Posted on December 23rd, 2016 by Betsy Davis in Pharma R&D
This week we want to introduce you to a small but ambitious biotech start-up based in Italy. Mauro Angiolini, Managing Director of Eudendron, explains how his company is working towards better cancer treatments. (more…)
